Fairscale Capital, LLC

Position in FTRE — Fortrea Holdings Inc.

CIK 2032350 NASHUA, NH

Position in FTRE

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$348

+$160 QoQ

Shares Held

0.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#306

of 331 holders

Holding Since

Jun 2024

9 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Fairscale Capital, LLC holds $8,514 across 5 Biotechnology names. FTRE ranks #4 (4.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INSM	INSMED Inc	37	$3,944
2	CRSP	CRISPR Therapeutics AG	59	$3,217
3	MRNA	Moderna, Inc.	14	$980
4	FTRE	Fortrea Holdings Inc. This page	20	$348
5	CTXR	Citius Pharmaceuticals, Inc.	42	$25

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$348	20	0.0%	Shares	Sole	2026-08-07
2026-03-31	$188	20	0.0%	Shares	Sole	2026-05-11
2025-12-31	$345	20	0.0%	Shares	Sole	2026-02-17
2025-09-30	$168	20	0.0%	Shares	Sole	2025-11-06
2025-06-30	$98	20	-83.5%	Shares	Sole	2025-08-12
2025-03-31	$913	121	-50.2%	Shares	Sole	2025-05-14
2024-12-31	$4,531	243	0.0%	Shares	Sole	2025-02-07
2024-09-30	$4,860	243	-26.1%	Shares	Sole	2024-11-12
2024-06-30	$7,678	329	—	Shares	Sole	2024-08-13
No filing history on record for this holder in this stock.